Hepatic overexpression of ATP synthase β subunit activates PI3K/Akt pathway to ameliorate hyperglycemia of diabetic mice

Diabetes

Volumn 63, Issue 3, 2014, Pages 947-959

  Wang, Chunjiong ^a,b   Chen, Zhenzhen ^a   Li, Sha ^a   Zhang, Yuan ^c   Jia, Shi ^a   Li, Jing ^a   Chi, Yujing ^a   Miao, Yifei ^a   Guan, Youfei ^a,d   Yang, Jichun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

^c PEKING UNIVERSITY THIRD HOSPITAL   (China)

^d Shenzhen University School of Medicine   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GLUCONEOGENESIS; HEP G2 CELLS; HUMANS; HYPERGLYCEMIA; LIVER; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIAL PROTON-TRANSLOCATING ATPASES; PHOSPHATIDYLINOSITOL 3-KINASES; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STREPTOZOCIN;

EID: 84894458421     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1096     Document Type: Article

References (55)

1. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14
2. Biddinger SB, Kahn CR. From mice to men: insights into the insulin resistance syndromes. Annu Rev Physiol 2006;68:123-158
3. Corriden R, Insel PA. Basal release of ATP: an autocrine-paracrine mechanism for cell regulation. Sci Signal 2010;3:re1
4. Yang J, Wong RK, Wang X, et al. Leucine culture reveals that ATP synthase functions as a fuel sensor in pancreatic beta-cells. J Biol Chem 2004;279: 53915-53923
5. Yang J, Wong RK, Park M, et al. Leucine regulation of glucokinase and ATP synthase sensitizes glucose-induced insulin secretion in pancreatic betacells. Diabetes 2006;55:193-201
6. Miyamoto A, Takeshita M, Pan-Hou H, Fujimori H. Hepatic changes in adenine nucleotide levels and adenosine 39-monophosphate forming enzyme in streptozotocin-induced diabetic mice. J Toxicol Sci 2008;33:209-217
7. Berglund ED, Lee-Young RS, Lustig DG, et al. Hepatic energy state is regulated by glucagon receptor signaling in mice. J Clin Invest 2009;119: 2412-2422
8. Serviddio G, Bellanti F, Tamborra R, et al. Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model. Eur J Clin Invest 2008;38:245-252
9. Szendroedi J, Chmelik M, Schmid AI, et al. Abnormal hepatic energy homeostasis in type 2 diabetes. Hepatology 2009;50:1079-1086
10. Schmid AI, Szendroedi J, Chmelik M, Krssák M, Moser E, Roden M. Liver ATP synthesis is lower and relates to insulin sensitivity in patients with type 2 diabetes. Diabetes Care 2011;34:448-453
11. Cooper ME, Regnell SE. The hepatic cannabinoid 1 receptor as a modulator of hepatic energy state and food intake. Br J Clin Pharmacol 2013 March 4 [Epub ahead of print]
12. Nair S, P Chacko V, Arnold C, Diehl AM. Hepatic ATP reserve and efficiency of replenishing: comparison between obese and nonobese normal individuals. Am J Gastroenterol 2003;98:466-470
13. Gómez-Valadés AG, Méndez-Lucas A, Vidal-Alabró A, et al. Pck1 gene silencing in the liver improves glycemia control, insulin sensitivity, and dyslipidemia in db/db mice. Diabetes 2008;57:2199-2210
14. Wu J, Wang C, Li S, et al. Thrsp promotes hepatic lipogenesis, and its expression LXRalpha through an SREBP1c-dependent mechanism. Baltimore, Md, Hepatology, 2013
15. Li J, Chi Y, Wang C, et al. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway. Hepatology 2011;53:1906-1916
16. Tamura Y, Ogihara T, Uchida T, et al. Amelioration of glucose tolerance by hepatic inhibition of nuclear factor kappaB in db/db mice. Diabetologia 2007;50:131-141
17. Kim KH, Jeong YT, Oh H, et al. Autophagy deficiency leads to protection from obesity and insulin resistance by inducing Fgf21 as a mitokine. Nat Med 2013;19:83-92
18. Pendse AA, Johnson LA, Tsai YS, Maeda N. Pparg-P465L mutation worsens hyperglycemia in Ins2-Akita female mice via adipose-specific insulin resistance and storage dysfunction. Diabetes 2010;59:2890-2897
19. Pei L, Waki H, Vaitheesvaran B, Wilpitz DC, Kurland IJ, Tontonoz P. NR4A orphan nuclear receptors are transcriptional regulators of hepatic glucose metabolism. Nat Med 2006;12:1048-1055
20. Yang J, Wang C, Li J, et al. PANDER binds to the liver cell membrane and inhibits insulin signaling in HepG2 cells. FEBS Lett 2009;583:3009-3015
21. Yang J, Gao Z, Robert CE, et al. Structure-function studies of PANDER, an islet specific cytokine inducing cell death of insulin-secreting beta cells. Biochemistry 2005;44:11342-11352
22. Abdul-Ghani MA, Muller FL, Liu Y, et al. Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance. Am J Physiol Endocrinol Metab 2008; 295:E678-E685
23. Franke H, Illes P. Involvement of P2 receptors in the growth and survival of neurons in the CNS. Pharmacol Ther 2006;109:297-324
24. Gonzales E, Julien B, Serrière-Lanneau V, et al. ATP release after partial hepatectomy regulates liver regeneration in the rat. J Hepatol 2010;52:54-62
25. Shin SY, Choi BH, Ko J, Kim SH, Kim YS, Lee YH. Clozapine, a neuroleptic agent, inhibits Akt by counteracting Ca2+/calmodulin in PTEN-negative U-87MG human glioblastoma cells. Cell Signal 2006;18:1876-1886
26. Katz S, Ayala V, Santillán G, Boland R. Activation of the PI3K/Akt signaling pathway through P2Y2 receptors by extracellular ATP is involved in osteoblastic cell proliferation. Arch Biochem Biophys 2011;513:144-152
27. Cheng Z, White MF. Targeting Forkhead box O1 from the concept to metabolic diseases: lessons from mouse models. Antioxid Redox Signal 2011;14:649-661
28. Kim HE, Lee SG. Induction of ATP synthase b by H2O2 induces melanogenesis by activating PAH and cAMP/CREB/MITF signaling in melanoma cells. Int J Biochem Cell Biol 2013;45:1217-1222
29. Xu C, Zhang X, Yu C, et al. Proteomic analysis of hepatic ischemia/ reperfusion injury and ischemic preconditioning in mice revealed the protective role of ATP5beta. Proteomics 2009;9:409-419
30. Ishikawa M, Iwamoto T, Nakamura T, Doyle A, Fukumoto S, Yamada Y. Pannexin 3 functions as an ER Ca(2+) channel, hemichannel, and gap junction to promote osteoblast differentiation. J Cell Biol 2011;193:1257-1274
31. Osorio-Fuentealba C, Contreras-Ferrat AE, Altamirano F, et al. Electrical stimuli release ATP to increase GLUT4 translocation and glucose uptake via PI3Kg-Akt-AS160 in skeletal muscle cells. Diabetes 2013;62:1519-1526
32. Urban D, Härtel FV, Gadiraju K, et al. Extracellular ATP attenuates ischemia-induced caspase-3 cleavage in human endothelial cells. Biochem Biophys Res Commun 2012;425:230-236
33. Emmett DS, Feranchak A, Kilic G, et al. Characterization of ionotrophic purinergic receptors in hepatocytes. Hepatology 2008;47:698-705
34. Feranchak AP, Fitz JG, Roman RM. Volume-sensitive purinergic signaling in human hepatocytes. J Hepatol 2000;33:174-182
35. Amaral SS, Oliveira AG, Marques PE, et al. Altered responsiveness to extracellular ATP enhances acetaminophen hepatotoxicity. Cell Commun Signal 2013;11:10
36. Barajas-López C, Espinosa-Luna R, Christofi FL. Changes in intracellular Ca2+ by activation of P2 receptors in submucosal neurons in short-term cultures. Eur J Pharmacol 2000;409:243-257
37. Cheng A, Wang S, Yang D, Xiao R, Mattson MP. Calmodulin mediates brain-derived neurotrophic factor cell survival signaling upstream of Akt kinase in embryonic neocortical neurons. J Biol Chem 2003;278:7591-7599
38. Sopasakis VR, Liu P, Suzuki R, et al. Specific roles of the p110alpha isoform of phosphatidylinsositol 3-kinase in hepatic insulin signaling and metabolic regulation. Cell Metab 2010;11:220-230
39. Kim JA, Kang YS, Lee SH, Lee EH, Yoo BH, Lee YS. Glibenclamide induces apoptosis through inhibition of cystic fibrosis transmembrane conductance regulator (CFTR) Cl(-) channels and intracellular Ca(2+) release in HepG2 human hepatoblastoma cells. Biochem Biophys Res Commun 1999;261: 682-688
40. Ma CJ, Nie AF, Zhang ZJ, et al. Genipin stimulates glucose transport in C2C12 myotubes via an IRS-1 and calcium-dependent mechanism. J Endocrinol 2013;216:353-362
41. Holland WL, Knotts TA, Chavez JA, Wang LP, Hoehn KL, Summers SA. Lipid mediators of insulin resistance. Nutr Rev 2007;65:S39-S46
42. Højlund K, Yi Z, Lefort N, et al. Human ATP synthase beta is phosphorylated at multiple sites and shows abnormal phosphorylation at specific sites in insulin-resistant muscle. Diabetologia 2010;53:541-551
43. Højlund K, Wrzesinski K, Larsen PM, et al. Proteome analysis reveals phosphorylation of ATP synthase beta-subunit in human skeletal muscle and proteins with potential roles in type 2 diabetes. J Biol Chem 2003;278: 10436-10442
44. Hirabara SM, Curi R, Maechler P. Saturated fatty acid-induced insulin resistance is associated with mitochondrial dysfunction in skeletal muscle cells. J Cell Physiol 2010;222:187-194
45. Mazibuko SE, Muller CJ, Joubert E, et al. Amelioration of palmitate-induced insulin resistance in C2C12 muscle cells by rooibos (Aspalathus linearis). Phytomedicine 2013;20:813-819
46. Gaster M. Insulin resistance and the mitochondrial link. Lessons from cultured human myotubes. Biochim Biophys Acta 2007;1772:755-765
47. Gao D, Nong S, Huang X, et al. The effects of palmitate on hepatic insulin resistance are mediated by NADPH Oxidase 3-derived reactive oxygen species through JNK and p38MAPK pathways. J Biol Chem 2010;285: 29965-29973
48. Ye J. Mechanisms of insulin resistance in obesity. Front Med 2013;7:14-24
49. Zhang BB, Zhou G, Li C. AMPK: an emerging drug target for diabetes and the metabolic syndrome. Cell Metab 2009;9:407-416
50. Foretz M, Hébrard S, Leclerc J, et al. Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy state. J Clin Invest 2010;120:2355-2369
51. Brunmair B, Staniek K, Gras F, et al. Thiazolidinediones, like metformin, inhibit respiratory complex I: a common mechanism contributing to their antidiabetic actions? Diabetes 2004;53:1052-1059
52. Stephenne X, Foretz M, Taleux N, et al. Metformin activates AMP-activated protein kinase in primary human hepatocytes by decreasing cellular energy status. Diabetologia 2011;54:3101-3110
53. Wang Y, Nishi M, Doi A, et al. Ghrelin inhibits insulin secretion through the AMPK-UCP2 pathway in beta cells. FEBS Lett 2010;584:1503-1508
54. Kim WH, Lee JW, Suh YH, et al. AICAR potentiates ROS production induced by chronic high glucose: roles of AMPK in pancreatic beta-cell apoptosis. Cell Signal 2007;19:791-805
55. Han Q, Zhang X, Xue R, et al. AMPK potentiates hypertonicity-induced apoptosis by suppressing NFkB/COX-2 in medullary interstitial cells. J Am Soc Nephrol 2011;22:1897-1911